Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 3Phase EARLY_PHASE1 1Phase 1 1

Status

Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 23Neoplasm Metastasis 10Stomach Neoplasms 5Colorectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Esophageal Neoplasms 3Brain Neoplasms 3Adenocarcinoma 3Triple Negative Breast Neoplasms 2Recurrence 2Neoplasms 2Meningeal Carcinomatosis 2HER2-positive Breast Cancer 2Breast Cancer With Brain Metastasis 2Unresectable Locally Recurrent Breast Cancer 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasm, Residual 1Inflammatory Breast Neoplasms 1HER2-negative Breast Cancer 1HER2-mutant Non-Small Cell Lung Cancer 1HER2-low Hormone Receptor Positive Breast Cancer 1Glioblastoma 1Gastrointestinal Neoplasms 1Gastric Adenocarcinoma 1Colonic Neoplasms 1Carcinoma 1

Interventions

Bevacizumab 234Fluorouracil 220Oxaliplatin 216Irinotecan 215Leucovorin 199Capecitabine 153Cetuximab 146Panitumumab 70Folfox protocol 51regorafenib 43Radiotherapy 38pembrolizumab 37IFL protocol 36HMPL-013 36trifluridine tipiracil drug combination 32Nivolumab 32Drug Therapy 26Neoadjuvant Therapy 24Trifluridine 18Celecoxib 18tislelizumab 17XELOX 17sintilimab 16Trastuzumab 16durvalumab 15atezolizumab 15aflibercept 15Chemotherapy, Adjuvant 15Biopsy 15apatinib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Colorectal Neoplasms × trastuzumab deruxtecan × Clear all
NCT04482309 2026-04-09

DPT02

AstraZeneca

Phase 2 Active not recruiting
477 enrolled 1 FDA
Gastrointestinal

Pancreatic Neoplasms, Colorectal Neoplasms

NCT05845450 2026-03-12

Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)

Gruppo Oncologico del Nord-Ovest

Phase 2 Recruiting
197 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07407465 2026-02-17

CHIMERA

Gruppo Oncologico del Nord-Ovest

Phase 2 Recruiting
42 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT04744831 2026-01-14

DESTINY-CRC02

Daiichi Sankyo

Phase 2 Completed
122 enrolled 21 charts 1 FDA
Gastrointestinal

Colorectal Neoplasms

NCT03384940 2021-10-18

DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01)

Daiichi Sankyo

Phase 2 Completed
86 enrolled 26 charts
Gastrointestinal

Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡